Literature DB >> 10604337

The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial.

J C Presti1, J J Chang, V Bhargava, K Shinohara.   

Abstract

PURPOSE: We define the optimal systematic biopsy regimen to detect carcinoma of the prostate.
MATERIALS AND METHODS: A total of 483 consecutive patients referred for an abnormal digital rectal examination and/or prostate specific antigen (PSA) 4.0 ng./ml. or greater underwent transrectal ultrasound and systematic biopsy. Lateral biopsies of the peripheral zone at the base and mid gland were added to the routine sextant biopsy regimen for a total of 10 systematic biopsies of the peripheral zone. Patients with a prostate greater than 50 cc also underwent systematic sextant transition zone biopsy in the mid lobar parasagittal plane. Detection rates of the various regions were assessed. Various biopsy schemes were then created and cancer detection rates were compared using McNemar's test.
RESULTS: Of the patients 42% (202 of 483) had cancer on biopsy. Traditional sextant biopsies missed 20%, while a sextant regimen incorporating lateral peripheral zone biopsies of the mid gland and base along with the apex missed 11% of the cancers. The combination of sextant and lateral peripheral zone biopsies (10-biopsy scheme) detected 194 cancers (96%). The 8 missed cancers were detected by lesion directed (5) or transition zone (3) biopsies. Eliminating the mid lobar base biopsies from the systematic 10-biopsy peripheral zone regimen resulting in an 8-biopsy peripheral zone regimen decreased detection from 96% to 95%.
CONCLUSIONS: The 6 systematic biopsies of the peripheral zone are inadequate and a minimum of 8, including the apex, mid lobar mid gland, lateral mid gland and lateral base, should routinely be performed.

Entities:  

Mesh:

Year:  2000        PMID: 10604337

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  65 in total

1.  Calibrating disease progression models using population data: a critical precursor to policy development in cancer control.

Authors:  Roman Gulati; Lurdes Inoue; Jeffrey Katcher; William Hazelton; Ruth Etzioni
Journal:  Biostatistics       Date:  2010-06-07       Impact factor: 5.899

2.  [Complications of transrectal prostate biopsy. Determination of current status].

Authors:  H W Gottfried; B Volkmer
Journal:  Urologe A       Date:  2003-08       Impact factor: 0.639

3.  CUA guidelines on prostate biopsy methodology.

Authors:  Assaad El-Hakim; Sabri Moussa
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

4.  An automated neural-fuzzy approach to malignant tumor localization in 2D ultrasonic images of the prostate.

Authors:  Samar Samir Mohamed; J M Li; M M A Salama; G H Freeman; H R Tizhoosh; A Fenster; K Rizkalla
Journal:  J Digit Imaging       Date:  2011-06       Impact factor: 4.056

5.  Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.

Authors:  Nagi B Kumar; Julio Pow-Sang; Kathleen M Egan; Philippe E Spiess; Shohreh Dickinson; Raoul Salup; Mohamed Helal; Jerry McLarty; Christopher R Williams; Fred Schreiber; Howard L Parnes; Said Sebti; Aslam Kazi; Loveleen Kang; Gwen Quinn; Tiffany Smith; Binglin Yue; Karen Diaz; Ganna Chornokur; Theresa Crocker; Michael J Schell
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-14

6.  Prostate biopsy: targeting cancer for detection and therapy.

Authors:  Samir S Taneja
Journal:  Rev Urol       Date:  2006

7.  Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom.

Authors:  George Lee; Kakahama Attar; Marc Laniado; Omer Karim
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

8.  Comparative effectiveness of alternative prostate-specific antigen--based prostate cancer screening strategies: model estimates of potential benefits and harms.

Authors:  Roman Gulati; John L Gore; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

Review 9.  Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Authors:  Richard Clements
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

Review 10.  Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.

Authors:  Martin Umbehr; Lucas M Bachmann; Ulrike Held; Thomas M Kessler; Tullio Sulser; Dominik Weishaupt; John Kurhanewicz; Johann Steurer
Journal:  Eur Urol       Date:  2008-10-18       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.